Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Axsome Therapeutics Showcases Innovation in Sleep Medicine with Multiple Presentations for AXS-12 and Solriamfetol at SLEEP 2025

AXSM : 104.10 (-2.02%)
Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

AXSM : 104.10 (-2.02%)
Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia

AXSM : 104.10 (-2.02%)
2 Soaring Stocks Wth More Upside Potential

SMMT : 19.78 (-1.88%)
AXSM : 104.10 (-2.02%)
Axsome Therapeutics to Participate in Upcoming Investor Conferences

AXSM : 104.10 (-2.02%)
Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

AXSM : 104.10 (-2.02%)
Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Hetero Labs Ltd.

AXSM : 104.10 (-2.02%)
3 High-Flying Stocks That Could Soar Even More

SMMT : 19.78 (-1.88%)
ALNY : 307.99 (+1.09%)
AXSM : 104.10 (-2.02%)
Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis

NFLX : 1,212.15 (-0.24%)
NVDA : 141.97 (-2.09%)
AXSM : 104.10 (-2.02%)
Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone

AXSM : 104.10 (-2.02%)

Barchart Exclusives

The Saturday Spread: KR, CAT and CLOV Show a Statistical Edge for Bullish Traders This Week
Conditional probability modeling shows potentially compelling opportunities in these three stocks to buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »